Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2026 16:10 ET | Source: Omada Health, Inc.

Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support

Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support
April 28, 2026 16:01 ET | Source: PMGC Holdings Inc.

UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders

UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions relate
January 08, 2026 09:00 ET | Source: Omada Health, Inc.

Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss

Omada Health’s new analysis adds to existing evidence that its GLP-1 companion program helps drive lasting, long-term weight loss
September 23, 2025 13:03 ET | Source: Shotsy Co.

UPDATE - Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...
September 23, 2025 08:45 ET | Source: Shotsy Co.

Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...
April 29, 2025 09:04 ET | Source: WW International Inc.

WeightWatchers Streamlines Member Access to Zepbound® Vials with LillyDirect® Pharmacy Provider

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”), the global leader in science-backed weight management, today announced a pharmacy...
March 31, 2025 08:32 ET | Source: Noom Inc

Noom To Streamline Access to Zepbound® Vials with Noom GLP-1 Companion Through Integration with LillyDirect® Pharmacy Provider

Noom announced an agreement with Eli Lilly and Company’s LillyDirect® pharmacy provider, Gifthealth, streamlining access to Zepbound® vials for members.
March 24, 2025 08:31 ET | Source: Sesame

Sesame, America’s Low-Cost Leader in Healthcare, Streamlines Access for Eligible Patients to Lilly’s Obesity Medicine Zepbound

NEW YORK CITY, March 24, 2025 (GLOBE NEWSWIRE) -- Sesame, the company that offers Americans quality, convenient health care at half the typical price, today announced a technical integration with...
February 20, 2025 08:30 ET | Source: Giftify, Inc.

Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ:GIFT) (the...
October 21, 2024 17:10 ET | Source: Mangoceuticals, Inc.

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness...